| Indicators | Browse All

Aclarion, Inc. (ACON)

Healthcare | Health Information Services | Broomfield, United States | NasdaqCM
2.40 USD -0.12 (-4.762%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 2.40

Short-term:★★☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 2:10 a.m. EDT

The immediate outlook is bearish as the stock trades significantly below its 50-day moving average, reflecting recent weakness where support levels have been breached. While the company recently secured financing and announced a share repurchase plan to shore up liquidity, these defensive moves come alongside a missed revenue estimate and a trailing twelve-month loss of nearly $7 per share. The valuation metrics are distorted by negative earnings, rendering traditional multiples useless, though the book value suggests the shares trade at a deep discount to assets. However, the long-term picture is severely compromised by a catastrophic multi-year decline; the price has erased virtually all gains over the last three years, with every single year showing negative returns. This persistent structural deterioration, combined with negative operating cash flow and a lack of analyst coverage, indicates that the market has lost faith in the business's ability to sustain growth or profitability. There is no dividend to provide income, and the combination of deteriorating fundamentals and a relentless downward price trajectory makes this a high-risk speculative vehicle rather than an investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.177396
MSTL0.192567
AutoETS0.196028
AutoARIMA0.197493

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 34%
H-stat 21.24
Ljung-Box p 0.000
Jarque-Bera p 0.402
Excess Kurtosis -0.38
Attribute Value
Sector Healthcare
Revenue per Share 0.057
Market Cap 6,917,690
Forward P/E -0.44
Beta 1.22
Previous Name Coin Gabbar
Website https://www.aclarion.com

Info Dump

Attribute Value
52 Week Change -0.6475525
Address1 8,181 Arista Place
Address2 Suite 100
All Time High 586,116.0
All Time Low 1.95
Ask 3.04
Ask Size 2
Average Daily Volume10 Day 89,480
Average Daily Volume3 Month 63,204
Average Volume 63,204
Average Volume10Days 89,480
Beta 1.216
Bid 1.78
Bid Size 2
Book Value 6.905
City Broomfield
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.4
Current Ratio 16.196
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 2.52
Day Low 2.355
Display Name Aclarion
Ebitda -9,468,166
Ebitda Margins 0.0
Enterprise To Ebitda 0.99
Enterprise To Revenue -111.948
Enterprise Value -9,377,772
Eps Current Year -4.51
Eps Forward -5.47
Eps Trailing Twelve Months -6.96
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.61458
Fifty Day Average Change -0.21457982
Fifty Day Average Change Percent -0.08207048
Fifty Two Week Change Percent -64.75525
Fifty Two Week High 12.03
Fifty Two Week High Change -9.629999
Fifty Two Week High Change Percent -0.8004987
Fifty Two Week Low 1.95
Fifty Two Week Low Change 0.45000005
Fifty Two Week Low Change Percent 0.23076925
Fifty Two Week Range 1.95 - 12.03
Financial Currency USD
First Trade Date Milliseconds 1,650,634,200,000
Float Shares 2,500,428
Forward Eps -5.47
Forward P E -0.43875688
Free Cashflow -5,323,035
Full Exchange Name NasdaqCM
Full Time Employees 10
Fullday Change -0.12
Fullday Change Percent -4.7619
Fullday Price 2.4
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.21755
Gross Profits 18,224
Has Pre Post Market Data 1
Held Percent Insiders 0.23976
Held Percent Institutions 0.040009998
Implied Shares Outstanding 2,882,371
Industry Health Information Services
Industry Disp Health Information Services
Industry Key health-information-services
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,743,120,000
Last Split Factor 1:27
Long Business Summary Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Long Name Aclarion, Inc.
Market us_market
Market Cap 6,917,690
Market State CLOSED
Max Age 86,400
Message Board Id finmb_108179695
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-08-28
Net Income To Common -9,196,562
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 7,090,632
Number Of Analyst Opinions 1
Open 2.52
Operating Cashflow -8,086,706
Operating Margins -115.031815
Payout Ratio 0.0
Phone 833 275 2266
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 2.4
Post Market Time 1,787,947,804
Prev Name Coin Gabbar
Previous Close 2.52
Price Eps Current Year -0.53215075
Price Hint 4
Price To Book 0.34757423
Price To Sales Trailing12 Months 82.58055
Profit Margins 0.0
Quick Ratio 15.742
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.12
Regular Market Change Percent -4.7619
Regular Market Day High 2.52
Regular Market Day Low 2.355
Regular Market Day Range 2.355 - 2.52
Regular Market Open 2.52
Regular Market Previous Close 2.52
Regular Market Price 2.4
Regular Market Time 1,787,947,201
Regular Market Volume 35,254
Return On Assets -0.37014
Return On Equity -0.58966
Revenue Growth 0.305
Revenue Per Share 0.057
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 2,882,371
Shares Percent Shares Out 0.0215
Shares Short 61,992
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 42,704
Short Name Aclarion, Inc.
Short Percent Of Float 0.0215
Short Ratio 1.31
Source Interval 15
State CO
Symbol ACON
Target High Price 7.5
Target Low Price 7.5
Target Mean Price 7.5
Target Median Price 7.5
Total Cash 16,295,462
Total Cash Per Share 5.653
Total Debt 0
Total Revenue 83,769
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -6.96
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.678485
Two Hundred Day Average Change -1.2784848
Two Hundred Day Average Change Percent -0.34755746
Type Disp Equity
Volume 35,254
Website https://www.aclarion.com
Zip 80,021